Products & Services.

M2R Tendon

M2R® is a brand-new, unique and medically stable tissue regeneration therapy that accelerates the healing process, regenerates tissue and minimizes scarring, producing no rejection or adverse effects. We have developed our first product, M2R® Tendon, which regenerates both muscle and tendon tissue. It has been successfully tested in laboratory animals and in culture human cells.

The results obtained represent a breakthrough. Our product cures in 100% of cases high-degree injuries within 2 to 7 days without scarring, or at least, with a very significant reduction in scar. This compares with between two and four weeks of recovery for similar injuries when using competitive products.  Other products not only produce scarring but, above all, all have a significant percentage of failure in healing. For our product M2R® Tendon, we have been approved by the Spanish Medicine and Sanitary Product Agency (AEMPS) stage II and III Clinical Trials for patients with injuries in the Patellar Tendon. We have recently inicitiated these Clinical Trials at the Hospitals of Grupo HM in Madrid which we will carry through the first quarter of 2018.

In order to accelerate patient access to our products, by the end of 2016 we created our first marketable product: an open PRP that uses our cell separation technology and, without having all the power of the M2R® line, it achieves a high degree of regeneration. This product is used since October 2017 by our team of Physicians to cure patients in our Regeneration Medicine Service at Clínica Corachan in Barcelona.

New Products under Development

Along with our tissue regeneration product we are working to provide physicians for a better use of our therapy through new products and a series of value added services intended to assist in its implementation and monitoring success while curing the patient.

Along with our tissue regeneration product we are working to provide physicians for a better use of our therapy through new products and a series of value added services intended to assist in its implementation and monitoring success while curing the patient.

Value added services will be mainly based on lesional control environment and provide real-time operating data of regenerative function.

New product development based on our M2R® technology is being done in our Laboratory through specific tissue research lines. Current research lines for future applications will include:

M2R Condral Repair
M2R Skin Repair
And, in collaboration with the research center of the University Hospital of Bellvitge (IDIBELL) in Barcelona, we are researching an application of our therapy for regeneration of kidney tissues after acute renal failure in order to recover its full functionality.

This line of work is our first approach to the application of therapy in internal vital organs. We believe it has the potential to open up an incredible number of possibilities to improve conditions that currently result in a high mortality rate. 

The company is managed by a highly qualified and experienced team of professionals, including scientists, health experts and managers with the ability to lead the development and commercialization of our products.

Contacta con nosotros

Offices Madrid

c/ General Pardiñas 29, 28001 Madrid, España

Offices Barcelona

c/ Roselló 161, Planta 7, 08036 Barcelona, España
info@m2rlab.com